Skip to content

Platelet Activation in Retinal Vein Occlusion

Platelet Activation in Branch Retinal Vein Occlusion

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12616001246471
Acronym
BRVO
Enrollment
60
Registered
2016-09-06
Start date
2016-08-01
Completion date
2016-09-30
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Purpose: To search platelet activation via detecting three important platelet activation parameters; Mean Platelet Volume (MPV), Platelet Distribution Width (PDW), and Plateletcrit (PCT) in patients with branch retinal vein occlusion (BRVO) in comparison to those in healthy adults as controls. Design: A prospective case control study Participants and Controls: 30 patients within the BRVO (Group 1) and 30 age-and sex-matched healthy controls will included into the study (Group 2). Methods: All patients and control subjects will undergo complete ophthalmologic evaluation. MPV, PDW, and PCT were measured in the studied groups. Main Outcome Measures: Alterations in platelet activation parameters. The mean level of MPV PDW and PCT value in Group 1 and in Group 2 will determined.

Interventions

Blood sampled will be collected in patients with acute branch retinal vein occlusion (BRVO). Platellet activation will be assessed. Patients with BRVO will be treated with conventional therapy. Duration of observation is 1 month.

Sponsors

Ankara Ulucanlar Eye Education and research hospital.
Lead SponsorHospital

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

We included the BRVO patients with posterior segment involvement.. The diagnosis of BRVO will reached using funud photography, flourescein angiography, and optical cohrence tomography. Patients and healthy volunteers that were matched for age and gender included in this study

Exclusion criteria

Patients and healthy volunteers who were on any kind of medication including corticosteroid and immunosuppressive therapy, who had smoking (smoke more than 1 cigarette per day) and drinking ( >1 standard drink per week) habits, or who had history of systemic and ocular disease will not included in the study

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026